Brought to you by:
Women’s Vascular Summit: Diving into issues around women’s vascular health and the female workforce
The Women’s Vascular Summit was established five years ago with the twin purposes of delving deeper into the issues that surround women’s vascular health and disparate outcomes, and establishing a venue where women vascular surgeons could help elevate and empower…
SVS mourns passing of former president
Society for Vascular Surgery (SVS) members are mourning the death of James (Jimmy) S.T. Yao, MD, 88, former SVS president and Lifetime Achievement Award recipient. Yao, professor emeritus at Northwestern University, died Tuesday, Dec. 20, in Chicago. He had been…
Students and residents: Attend VAM 2023 on a scholarship
Medical students and general surgery residents have the chance to change their lives. Perhaps they are still seeking some direction for their medical careers. Perhaps they’re considering vascular surgery but aren’t sure that’s right for them. A trip to the Society…
‘Impressive’ 12-month Flex vessel prep data presented at VEITHsymposium
VentureMed Group, a medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for peripheral arterial disease (PAD), announced data presented at the 2022 VEITHsymposium (Nov. 15–19) in New York City that demonstrated that Flex…
VSGBI spotlights data-driven financial incentives for PAD revascularization
The President’s Symposium at the Vascular Society of Great Britain and Ireland (VSGBI) annual scientific meeting (Nov. 23–25) in Brighton, England, saw Rob Sayers, MD, from the University of Leicester, presenting, “CLTI CQUIN [Commissioning for Quality and Innovation] has raised…
SVS issues membership dues reminder
To avoid a lapse in their benefits, Society for Vascular Surgery (SVS) members are encouraged to pay their 2023 member dues by Dec. 31. These benefits of SVS membership include access to the Journal of Vascular Surgery publications at reduced…
Paclitaxel DCB performs well in ‘challenging anatomy’ of femoropopliteal in-stent restenosis, VQI registry data show
The IN.PACT Admiral drug-coated balloon (DCB) shows promising results in treating femoropopliteal in-stent restenosis (ISR) in a Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry-based, postmarket surveillance study. This is according to Daniel Bertges, MD, a vascular surgeon…
Voting on SVS bylaws revisions ends Dec. 18
Active and Senior Society for Vascular Surgery (SVS) members in good standing have until Dec. 18 to cast their ballots to change the composition of the Society’s Nominating Committee. Online voting began Dec. 1 on consideration of three revisions to…
Efemoral Medical closes financing round to fund ongoing study of its vascular scaffold system
Efemoral Medical has today announced the closing of its $4.9 million preferred Series A1 round. Supported by existing investors as well as an experienced cohort of new investors, the proceeds will further Efemoral’s device development and expand enrollment in its…
EU Commission to propose delay to MDR implementation
Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the transition period for the implementation of the European Union’s (EU) Medical Device Regulation (MDR) will be put forward in early 2023. Kyriakides informed health ministers from the EU’s…